Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study. Issue 3 (21st December 2021) - Visentin, Andrea; Mauro, Francesca Romana; Cibien, Francesca; Vitale, Candida; Reda, Gianluigi; Fresa, Alberto; Ciolli, Stefania; Pietrasanta, Daniela; Marchetti, Monia; Murru, Roberta; Gentile, Massimo; Rigolin, Gian Matteo; et al.